Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00574756 · ClinicalTrials.gov registry record · NA
Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction
A NA study, sponsored by University of California, San Diego.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT00574756: Clinical Trial NA study, sponsored by University of California, San Diego.
NCT00574756 is a NA study that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00574756, a NA study, was terminated before completion, sponsored by University of California, San Diego.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of ranolazine, an FDA-approved medication for the treatment of angina, on heart function by using echocardiography.
Interventions
- DRUG ranolazine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-03 |
| Phase | NA |
Why NCT00574756 stopped before completion
NCT00574756 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which ranolazine is the first listed.
NCT00574756 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00574756 about?
NCT00574756 is a clinical study titled "Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction". The purpose of this study is to evaluate the effects of ranolazine, an FDA-approved medication for the treatment of angina, on heart function by using echocardiography.
What is the current status of trial NCT00574756?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2007-12. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00574756?
The interventions under investigation include: ranolazine (DRUG).
Who is sponsoring clinical trial NCT00574756?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00574756's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia